https://www.avient.com/investor-center/news/polyone-board-elects-robert-abernathy-director
View original content:http://www.prnewswire.com/news-releases/polyone-board-elects-robert-abernathy-as-director-300610301.html
https://www.avient.com/investor-center/news/polyone-appoints-michael-garratt-chief-commercial-officer-donald-k-wiseman-president-performance-products-solutions
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/polyone-appoints-michael-a-garratt-as-chief-commercial-officer-donald-k-wiseman-as-president-of-performance-products--solutions-300234331.html
https://www.avient.com/investor-center/news/polyone-appoints-walter-ripple-vice-president-sustainability-joins-alliance-end-plastic-waste-founding-member
View original content:http://www.prnewswire.com/news-releases/polyone-appoints-walter-ripple-as-vice-president-sustainability-joins-alliance-to-end-plastic-waste-as-founding-member-300780572.html
https://www.avient.com/investor-center/news/polyone-announces-michael-garratt-serve-interim-president-specialty-engineered-materials
View original content:http://www.prnewswire.com/news-releases/polyone-announces-michael-a-garratt-to-serve-as-interim-president-of-specialty-engineered-materials-300639275.html
https://www.avient.com/investor-center/news/polyone-announces-acquisition-plasticomp
View original content:http://www.prnewswire.com/news-releases/polyone-announces-acquisition-of-plasticomp-300658009.html
https://www.avient.com/investor-center/news/polyone-design-expertise-and-advanced-materials-accelerate-innovation-outdoor-high-performance-industry
View original content:http://www.prnewswire.com/news-releases/polyone-design-expertise-and-advanced-materials-accelerate-innovation-in-outdoor-high-performance-industry-300584221.html
https://www.avient.com/products/polymer-colorants/fiber-colorants/magiq-liquid-fiber-additives-and-colorants
Discover how our fiber tracer technology can help confirm the origin of fibers in your textile products
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_Elastomers_with_Universal_Bonding_Characteristics.pdf
TPE-1A peel adhesion 0 1 2 3 P ee l s tr en g th : N /m m 25mm/sec 38mm/sec 51mm/sec 64mm/sec D040W6 Lexan 141 Cycolac NA1000 2 . 8 2 . 82 . 82 . 8 1. 9 2 . 42 . 42 . 42 . 4 1. 9 2 . 1 1. 9 Figure 7.
https://www.avient.com/sites/default/files/2021-12/AVNT 2021 Investor Day_0.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues; • Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Color business, including any expected synergies; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Our ability to consummate and successfully integrate acquisitions; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended 31 de diciembre de 2020 under Item 1A, “Risk Factors.” Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Healthcare 8–10% Composites 10% Asia / LATAM 5% Other (GDP growth) 2–3% Avient 6.5% Avient Corporation 14 Avient Corporation 15 Clariant: Better Together Norbert Merklein • Geographic footprint – Complementary not overlapping. Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA Avient reflects 2021 Adjusted EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of 2 de diciembre de 2021 High Free Cash Flow Conversion Avient Specialty Formulators Other Specialty / Chemical Companies Avient Corporation 131 12% 16% 15%+ 20%+ 16% 16% 16% 14% 14% 14% 34% 26% 25% 22% 21% 16% 15% 12% 9% 8% A V N T K W R A V Y P P G F U L R P M G C P C E F M C A S H E M N E C L H U N H X L S C L B N R U N V R EBITDA Margins Avient reflects 2021 Adjusted EBITDA of $580M and guided revenue of $4,750M.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Any such statement, sample or other information of Seller in relation to the Specifications, the Products and the use thereof are furnished for the accommodation of Buyer only and are not warranties or representations of performance 14. Seller may terminate these Terms at its sole option upon 14 calendar days’ written notice to Buyer. 23. Personal Information' means information relating to any person, including but not limited to: (i) information relating to the race, gender, sex, pregnancy, marital status, national, ethnic or social origin, colour, sexual orientation, age, physical or mental health, well-being, disability, religion, conscience, belief, culture, language and birth of the person; (ii) information relating to the education or the medical, financial, criminal or employment history of the person; (iii) information relating to the financial affairs of the person; (iv) credit card details and transactional data; (v) any identifying number, symbol, e-mail address, physical address, telephone number or other particular assignment to the person; (vi) biometric information about a person; (v) personal opinions, views and preferences of a person; (vii) correspondence sent by the person that is implicitly or explicitly of a private or confidential nature or further correspondence that would reveal the contents of the original correspondence; (viii) the views or opinions of another individual about the person; (ix) the name of the person if it appears with other personal information relating to the person or if the disclosure of the name itself would reveal information about the person; and (x) any other information which may be treated or defined as "personal information" in terms of any applicable laws, including Data Protection Legislation.